Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

Plus more pharma news from the Pharmalittle newsletter.

It is not clear whether Prasad will still serve as the agency’s chief medical and scientific officer, Stat reports. Meanwhile, Center for Drug Evaluation and Research staff grill top drug regulator ...

U.S. stock futures inched higher on Monday, with gains restrained ahead of key inflation data due later this week. Here are ...